default author photo

Rashmi Ravichandran

University of Washington - Department of Biochemistry

1705 NE Pacific St.

Health Sciences Building, J-Wing, Room J405

Seattle, WA 98195-735

United States

SCHOLARLY PAPERS

2

DOWNLOADS

120

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

De novo Design of a Highly Specific Inhibitor of Integrin Αvβ6 for Pulmonary Fibrosis

Number of pages: 55 Posted: 11 Mar 2021
University of Washington - Department of Biochemistry, University of Washington - Department of Biochemistry, Brigham Young University - Department of Chemistry and Biochemistry, Harvard Medical School - Program in Cellular and Molecular Medicine, Harvard Medical School - Program in Cellular and Molecular Medicine, Brigham Young University - Department of Chemistry and Biochemistry, Stanford University - Department of Bioengineering, Brigham Young University - Department of Chemistry and Biochemistry, Brigham Young University - Department of Chemistry and Biochemistry, University of Washington - Department of Biochemistry, University of Washington - Department of Biochemistry, University of Washington - Department of Biochemistry, University of Washington - Department of Materials Science and Engineering, University of Washington - Department of Biochemistry, University of Washington - Department of Biochemistry, University of Washington - Department of Biochemistry, AstraZeneca - Bioscience COPD/IPF, AstraZeneca - Research and Early Development, AstraZeneca - Antibody Discovery and Protein Engineering, University of Washington - Department of Biochemistry, University of Washington - Department of Biochemistry, University of Washington - Center for Lung Biology, University of Washington - Division of Pulmonary, Critical Care and Sleep Medicine, University of Washington - Department of Biochemistry, University of Washington - Department of Medicine, Stanford University - Department of Bioengineering, Brigham Young University - Department of Chemistry and Biochemistry, Harvard Medical School - Program in Cellular and Molecular Medicine and University of Washington - Department of Biochemistry
Downloads 69 (883,195)

Abstract:

Loading...

2.

Two-Component Spike Nanoparticle Vaccine Protects Macaques from SARS-CoV-2 Infection

Number of pages: 42 Posted: 24 Nov 2020
University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology, University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), University of Amsterdam - Department of Medical Microbiology and Infection Prevention, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology, University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Life and Soft, Institut Cochin, University of Southampton - School of Biological Sciences, University of Southampton - School of Biological Sciences, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology, Université Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and bacterial diseases (IMVA-HB/IDMIT), University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Amsterdam Institute for Infection and Immunity, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, Erasmus Medical Center - Viroscience Department, Erasmus Medical Center - Department of Viroscience, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology, University of Washington - Department of Biochemistry, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, University of Amsterdam - Department of Medical Microbiology, Université Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and bacterial diseases (IMVA-HB/IDMIT), Université Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and bacterial diseases (IMVA-HB/IDMIT), AIMM Therapeutics BV, University of Amsterdam - Department of Medical Microbiology, University of Amsterdam - Department of Medical Microbiology, Erasmus Medical Center - Viroscience Department, University of Amsterdam - Amsterdam Public Health Research Institute, Life and Soft, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, University of Southampton - School of Biological Sciences, University of Washington - Department of Biochemistry, University of Paris-Saclay - Molecular Genetics of RNA Viruses, University of Amsterdam - Department of Medical Microbiology, University of Paris-Saclay - Center for Immunology of Viral, Auto-immune, Hematological and Bacterial Diseases (IMVA-HB/IDMIT) and University of Amsterdam - Department of Medical Microbiology
Downloads 51 (1,052,702)

Abstract:

Loading...

SARS-CoV-2 vaccine, Self-assembling protein nanoparticle vaccine, SARS-CoV-2 NHP challenge study